Hematology and Oncology
Home Hematology and Oncology
FDA: Risk From Tainted Blood Pressure Drugs Very Low
Officials say actual risk to patients from tainted medications is likely lower than originally stated
Cancer Survivors Face Long-Term Cardiovascular Risk
Risk varies by cardiovascular outcome and site of 20 common cancers
Salvage Therapy Does Not Up Survival for Progressive Myeloma
Deepening of response through salvage therapy not linked to improved progression-free, overall survival
Physical Activity, Overall Survival Not Linked in Metastatic CRC
Nine or more MET hours per week tied to lower risk for grade ≥3 treatment-related adverse events
Low Nurse and Support Staffing Tied to Higher Inpatient Mortality
Effect on patient mortality risk may be intensified when both RN, nursing support staffing are low
Dipeptidyl Peptidase-4 Inhibitors May Up Pancreatic Disease Risk
Risks for pancreatitis, pancreatic cancer higher in Korean patients with newly diagnosed T2DM
CT Scan Screen for Lung Cancer Can ID Smoking-Related Diseases
New diagnoses of CVD, emphysema, osteoporosis identified, often are linked to adverse events
Psoriasis Independently Linked to Increased Mortality Risk
Comorbidities such as CVD, diabetes, COPD, cancer, CKD, and stroke mediate part of the association
Few Oncologists Suggest Health Promotion to Cancer Survivors
Oncologists expressed concern that health promotion could distress or overwhelm cancer survivors
DEA to Approve Dozens More Growers for Marijuana Research
Added sites will provide researchers with greater variety of marijuana to study
